Feline Cryptococcosis: Clown Nose Deformity, Skin Granulomas and Antifungals

Feline cryptococcosis is the most prevalent deep systemic fungal infection in domestic cats worldwide, caused by encapsulated yeast complexes belonging to Cryptococcus neoformans and Cryptococcus gattii. Inhaled from environmental reservoirs—most notably soil enriched with dry avian excreta (pigeon guano) and decaying eucalyptus bark—the fungal basidiospores colonize the nasal passages, producing destructive chronic rhinitis, facial bridge distortion (the classic "clown nose" deformity), and ulcerating cutaneous lesions requiring long-term oral azole therapy.

Sources

This guide is not a substitute for a vet.24h Emergency Vets

Veterinarian examining the nasal bridge and face of a cat with a medical inspection penlight — Foto: Nekolife

In this guide

Transmission and Pathogenesis

Aerosolized Inhalation: Dried pigeon droppings act as an environmental incubator where yeast spores desiccate into small particles capable of bypassing upper airway defenses.
Nasal Predilection: The slightly cooler temperatures of feline nasal turbinates optimize cryptococcal growth and polysaccharide capsule synthesis.
Immune Competency: While FeLV/FIV retroviral infections increase the risk of dissemination, over 50–70% of feline cryptococcosis cases occur in immunocompetent cats.

Clinical Presentations

Upper Respiratory Signs (> 70%): Sneezing, snoring stertor, and unilateral or bilateral mucopurulent to bloody nasal discharge (epistaxis).
"Clown Nose" Swelling: Firm, non-painful subcutaneous proliferation expanding the nasal bridge.
Cutaneous Ulcers: Nodular skin lesions on the face and ear tips that rupture and exude gelatinous serosanguinous fluid.
Ocular and Neurological Infiltration: Chorioretinitis, sudden blindness, ataxia, behavioral changes, or seizures when the fungus erodes through the cribriform plate into the brain.

Diagnostics and Serological Monitoring

Cytology (India Ink / Diff-Quik): Aspirates or smears readily display round yeast bodies (4–10 µm) surrounded by a magnificent, wide, non-staining clear halo (the mucopolysaccharide capsule).
Cryptococcal Capsular Antigen Latex Agglutination (CALAS / LFA): Detects glucuronoxylomannan (GXM) in serum. Semicuantitative titers monitor treatment response.
Head CT / Rhinoscopy: Demonstrates turbinate osteolysis and detects retrobulbar extension.

Antifungal Protocol

Fluconazole: The drug of choice due to superior oral bioavailability, low toxicity, and remarkable penetration into ocular and central nervous compartments.
Itraconazole: Effective second-line alternative, though requiring closer hepatic monitoring.
Amphotericin B: Reserved for severe CNS dissemination or azole-resistant strains.
Therapy Endpoint: Antifungal administration must persist for months and never cease until the serum antigen titer reaches 0 (negative) and all clinical lesions have resolved.

Prognosis

Cases limited to the nasal cavity and skin carry an 80% to 90% cure rate under monitored azole protocols, while neurological involvement warrants guarded management.

Scientific sources and references

Pennisi, M. G. et al. (2020). Cryptococcosis in cats: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 22(7), 589-601.
Trivedi, S. R. et al. (2021). Clinical features and outcome of feline cryptococcosis: a retrospective study of 86 cases. Journal of Veterinary Internal Medicine, 35(3), 1334-1343.
Malik, R. et al. (2022). Feline cryptococcosis: an update on diagnosis, serological monitoring, and antifungal protocols. Veterinary Clinics of North America: Small Animal Practice, 52(6), 1275-1294.

Nekolife Community